Biocept Reports First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Biocept Reports First Quarter 2021 Financial Results

Biocept (BIOC) Tops Q1 EPS by 19c

May 12, 2021 4:24 PM EDT

Biocept (NASDAQ: BIOC) reported Q1 EPS of $0.19, $0.19 better than the analyst estimate of $0.00. Revenue for the quarter came in at $17.8 million versus the consensus estimate of $13.67 million.

We are reporting profitability for the second consecutive quarter on revenues of $17.8 million, as our dedicated Biocept team continued to serve our community with COVID-19 RT-PCR testing featuring exceptional customer service and rapid turnaround times, said Michael Nall, Biocepts President and CEO. These outstanding financial results support further advancements with our core oncology business and more specifically our focus on neuro-oncology as we build for a strong... More